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We developed a method for the efficient generation of functional
dopaminergic (DA) neurons from human embryonic stem cells
(hESCs) on a large scale. The most unique feature of this method
is the generation of homogeneous spherical neural masses (SNMs)
from the hESC-derived neural precursors. These SNMs provide
several advantages: (i) they can be passaged for a long time
without losing their differentiation capability into DA neurons; (ii)
they can be coaxed into DA neurons at much higher efficiency than
that from previous reports (86% tyrosine hydroxylase-positive
neurons/total neurons); (iii) the induction of DA neurons from
SNMs only takes 14 days; and (iv) no feeder cells are required
during differentiation. These advantages allowed us to obtain a
large number of DA neurons within a short time period and
minimized potential contamination of unwanted cells or patho-
gens coming from the feeder layer. The highly efficient differen-
tiation may not only enhance the efficacy of the cell therapy but
also reduce the potential tumor formation from the undifferenti-
ated residual hESCs. In line with this effect, we have never
observed any tumor formation from the transplanted animals used
in our study. When grafted into a parkinsonian rat model, the
hESC-derived DA neurons elicited clear behavioral recovery in
three behavioral tests. In summary, our study paves the way for the
large-scale generation of purer and functional DA neurons for
future clinical applications.
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Parkinson’s disease (PD) is a neurodegenerative disorder char-acterized by progressive and selective loss of dopaminergic
(DA) neurons in the midbrain substantia nigra (1). Currently, the
prevailing strategy for the treatment of PD is pharmacological.
However, pharmacological treatment with L-DOPAworks initially,
but over time, the effectiveness of L-DOPA wanes and side effects
develop (2). An alternative approach may be the transplantation of
DA-synthesizing cells. One source of DA-synthesizing cells is
embryonic stem cells (ESCs). ESCs are pluripotent and capable of
self-renewal (3–5). For the purpose of applying the ESCs to PD,
many researchers have tried to develop protocols by which ESCs
from some species can differentiate into DA neuronal phenotypes
(6–11). Although some progress has been made in the generation
of DA neurons from human ESCs (hESCs) (12–22), there are still
many technical improvements to be made before the application of
hESCs to treat PD. Examples include increasing the purity of DA
neurons, supplying a sufficient quantity of DA neurons for clinical
applications, decreasing tumor formation after transplantation, and
clearly demonstrating the functionality of hESC-derived DA neu-
rons in a parkinsonian animal model.
Here, we introduce a method that allows us to differentiate
hESCs into functional tyrosine hydroxylase-positive (TH) neu-
rons up to near 86% of the total hESC-derived neurons, which is
the highest purity ever reported. Achieving high efficiency of DA
neuronal derivation is an important issue in cell therapy, because it
would not only increase the efficacy of the therapy but also
minimize potential disastrous side effects such as teratoma resulting
from undifferentiated residual ES cells.
The unique feature of our protocol is the generation of pure
spherical neural masses (SNMs). The SNMs can be expanded for
long periods without losing their differentiation capability and be
coaxed into DA neurons efficiently within a relatively short time
(2 weeks) when needed. The SNM culture and DA neuron
derivation from the SNMs do not need feeder cells, which reduces
the risk of contamination of unwanted cells and pathogens. More
importantly, our hESC-derived DA neurons induced clear behav-
ioral recovery in three behavioral tests after transplantation in a
parkinsonian rat model, indication their functionality in vivo; these
behavioral data would clarify a recent heated debate about the
behavioral recovery by hESC-derived DA neurons in a rat parkin-
sonian model (14, 23).
Results
Differentiation of hESCs into TH Neurons. In this study, we tried to
develop an efficient method for generating DA neurons from
hESCs at a high purity and on a large scale. First, detached hESC
colonies were cultured on bacterial dishes to form embryoid bodies
(EBs) as described in Experimental Procedures. For the selection of
neural precursors (NPs), the EBs were transferred onto the
Matrigel-coated culture dishes and cultured in the presence of 0.5%
N2 supplement for 5 days (Fig. 1, stage 1). The selected NPs then
were expanded in the presence of basic FGF (bFGF) and N2
supplements for 4 days. Most of the selected and expanded NPs
expressed nestin and musashi, the markers for NPs (data not
shown) (24) and formed neural clumps with neural rosettes (Fig.
1C) or neural tube-like morphologies (Fig. 1D) (16–17). These
neural clumps were isolated mechanically and cultured in suspen-
sion on bacterial dishes in the presence of bFGF and N2 supple-
ments. After approximately 10 days in this culture condition, SNMs
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that resemble ‘‘neurospheres’’ (25) were formed. For passage, the
SNMs were mechanically dissected into 4–6 fragments and
expanded for7–10 days before the next passage. During the first
passage, portions with nonneural morphologies (e.g., cystic struc-
tures or spot-forming fibroblast-like cells) were removed by me-
chanical cutting, increasing the homogeneity of the SNMs. This
process was repeated three times (for a total of four passages) to
obtain highly homogeneous SNMs. The SNMs could be expanded
for at least 120 days, suggesting that our SNM cultures could
provide enough number of cells for therapy.
To differentiate the SNMs into neurons, we transferred the
SNMs onto Matrigel-coated culture dishes containing differentia-
tion medium (Fig. 1, stage 2). A few days later, cells displayed
neuronal morphologies with processes (Fig. 1F) and expressed the
neuronal markers III-tubulin and NeuN (data not shown). To
induce TH neurons from the cells with neuronal phenotypes,
SHH and FGF8 were added into the differentiation medium for 10
days (Fig. 1 G and H). Cells then were treated with ascorbic acid
(AA) for the last 6 days of the 10-day procedure to induce TH cell
maturation (Fig. 1H).
After differentiation into TH neurons, immunostaining was
performed by using antibodies against TH and III-tubulin (Fig. 1
I–K). When counted at the cellular level,86 1.4% (4–5 105
cells per 35-mm culture dish) of the III-tubulin-expressing cells
(total neurons) were TH neurons (Fig. 2A). Flow cytometry
analysis (Fig. 2B) revealed that 85% of these neurons expressed
TH, which is consistent with the cell-counting result. In addition,
77% of the total differentiated cells were III-tubulin neurons.
These results suggest that our protocol could generate TH neu-
rons from hESCs much more efficiently than previous protocols
(13–18). We also applied our protocol to other hESC lines, such as
SNUhES3 and SNUhES16, to confirm that the efficient generation
of DA neurons by our protocol is not specific to a certain cell line.
After final differentiation, 77.18 1.36% and 81.74 1.52% of the
total neurons were TH in SNUhES3 and SNUhES16, respectively
(Fig. 2 D–I andM), suggesting that our protocol can be applicable
to any hESC line. Interestingly, after 10 passages, the SNMs also
retained a similar potential for differentiation into DA neurons
(Fig. 2 J–L).
The efficiency of DA neuron differentiation also was analyzed at
the colony level. This analysis was performed on day 7 during the
14-day differentiation period because individual colonies are hard
to distinguish on day 14 of the differentiation procedure. Despite
being counted in the middle of differentiation procedure (at day 7),
the majority of the colonies (93.38  2.72% from SNUhES1,
91.89  2.48% from SNUhES3, and 92.63  2.43% from SNU-
hES16) still contained TH cells. These numbers also are higher
than that from the previous study that demonstrated that 87% of
the colonies contained TH cells (19).
Characterization of the hESC-Derived TH Neurons. We next charac-
terized the subtypes of the hESC-derived TH cells because
noradrenergic and adrenergic neurons also express TH. To do so,
cells were coimmunostainedwithTHand eitherEn1 (midbrainDA
neuron marker), aromatic amino acid decarboxylase (AADC;
marker for both catecholaminergic and serotonergic neurons),
Fig. 1. Differentiation of hESCs into TH neurons. Schematic procedures for
the in vitro differentiation of hESCs. NPs with neural rosettes (C) and neural-
tube-like structures (D) were produced by neural selection and expansion
procedures after EB formation (B). An SNM (E) was then made by using these
NPs in a suspension culture (stage 1). After four passages, the SNMs were
differentiated into THneurons by treating the cells with signaling molecules,
such as SHH, FGF8, and AA (stage 2). The detection of TH (I) and III-tubulin
cells (J) from differentiated hESCs was performed by immunocytochemistry.
Fig. 2. Quantitative analysis of TH and III-
tubulin neurons and the differentiation of
TH neurons from other hESC lines and highly
passaged SNMs. (A) The proportion of THneu-
rons to the total number of neurons. TH and
III-tubulin neurons (15,000 cells from three
independent experiments) were counted after
performing immunocytochemistry. The value
represents the mean  SEM. (B and C) Flow
cytometric analysis of TH and III-tubulin
neurons. Anti-III-tubulin and anti-TH antibod-
ies were used for the detection of total neurons
and TH neurons. Stained cells were analyzed
by using a FACScan. This analysis revealed that
85% (65.3%/77.1%84.7%) of the total neu-
rons were TH neurons, and77% of all of the
cellswereneurons (B, sampleanalysis;C, control
without primary antibody treatment). (D–L) De-
tection of III-tubulin (green; D, G, and J) and
TH (red; E, H, and K) cells after hESC differen-
tiation.SNUhES3(passagefour;D–F), SNUhES16
(passage four; G–I), and SNUhES1 (highly pas-
saged SNM, passage 10; J–L) were used. (M) TH
and III-tubulin neurons (5,000 cells from
five independent samples) that were derived
fromtheSNUhES3andSNUhES16cell lineswere
counted after performing immunocytochemis-
try. The value represents the mean SEM.














dopamine -hydroxylase (DBH; norepinephrine neuron marker),
or phenylethanolamine N-methyltransferase (PNMT; epinephrine
neuron marker) (Fig. 3 A–L). Most TH cells expressed AADC
(Fig. 3 A–C), and 91.61 0.64% (3.6–4.6 105 cells per 35-mm
culture dish) of the TH cells also expressedEn1 (Fig. 3D–F). Only
a few TH cells expressed DBH (4.18  0.50%; Fig. 3 G–I) or
PNMT (4.44  0.57%; Fig. 3 J–L), indicating that the majority of
TH cells are DA neurons. We noticed that some (5%) of
PNMT cells (Fig. 3K) were TH and did not have a neuronal
morphology. The identity of these cells is yet to be determined. Our
hESC-derived TH cells also did not express GABA (Fig. 4M–O),
therefore indicating that they are not olfactory DA neurons. GFAP
and O4, which are markers for astrocyte and oligodendrocyte,
respectively, also were not detected (data not shown).
During our procedure for differentiating hESCs to DA neurons,
the change of several markers was analyzed by semiquantitative
RT-PCR. (Fig. 3P).Oct4, amarker for undifferentiated hESCs, was
detected only at the ES stage, but not after the initiation of
differentiation.At the SNMstage, theNPmarkers such as Pax6 and
Sox1 were strongly up-regulated, and intriguingly, Nurr1, a tran-
scription factor involved in the early specification of DA neurons,
already was expressed. At the end of the differentiation procedure,
the expression of midbrain DA neuronal markers, such as Nurr1,
En1, and Pitx3 were prominent. However, as expected, DBH was
hardly detectable. Collectively, the RT-PCR results (Fig. 3P) are in
line with the immunostaining results (Fig. 3 A–O), thus indicating
that most of the TH neurons generated from our protocol are
midbrain DA neurons.
Functional Analyses of DA Neurons. To explore whether the hESC-
derived DA neurons were biologically functional, some of the
neuronal properties were examined. First, the electrophysiological
properties of differentiated neurons were investigated. Recordings
in the current-clamp configuration allowed us to determine the
active membrane characteristics of these neurons. Prolonged de-
polarizing current injections demonstrated the capability of the cell
to fire fast action potentials and action potential series (Fig. 4A).
The neurons also exhibited voltage-dependent membrane currents.
Depolarizing voltage steps elicited both large outward potassium
currents and fast inward Na currents (Fig. 4B). These results
indicate that the differentiated cells have the characteristics of
neurons. Additionally, to determine whether these neurons retain
normal synapse-forming activity, the differentiated cells were co-
immunostainedwith antibodies against THand synaptophysin (Fig.
4 C–E). Synaptophysin, a membrane glycoprotein of synaptic
vesicles that exists in all neurons, is known to be essential for
synapse formation and has been widely used as a marker for nerve
terminals. As shown in Fig. 4 C–E, the TH cells expressed
synaptophysin, which indicates that the cells have the potential to
form synapses (17). An important physiological aspect of the in vitro
differentiated DA neurons is their ability to produce and release
DA in response to membrane depolarization. To test this aspect,
hESC-derived DA neurons were analyzed for the production and
release of DA. The 24-h conditioned media was prepared at
differentiation day 14, and cells then were treated with 50 mMKCl
for 30 min. From these samples, DA levels were assayed by
reverse-phase HPLC. As shown in Fig. 4F, DA released into the
conditioned media (24 h) and in response to membrane depolar-
ization (30 min) were 3.24  104 and 3.08  104 pmol per cell,
respectively. DA was not detected in the control medium. These
results indicate that the neurons derived from hESCs by using our
protocol retained the functional properties of DA neurons.
Behavioral Recovery After Transplantation in a Parkinsonian Rat
Model. To examine the in vivo effect of the hESC-derived DA
neurons, we performed several behavioral tests by using a unilat-
erally lesioned parkinsonian rat model. The PD model was gener-
ated by injecting the 6-hydroxydopamine (6-OHDA) into the
medial forebrain bundle unilaterally, and the model was validated
by an increase in the amphetamine- and apomorphine-induced
rotation and a reduction in the forepaw stepping number (‘‘Pre’’ in
Fig. 5). The severity of lesions also was checked by assessing the loss
Fig. 4. The hESC-derived DA neurons are biologically functional. (A and B)
Electrophysiological properties of DA neurons differentiated from hESCs. (A)
Current-clamp recordings during prolonged depolarizing current injections.
Bottom traces represent current injections, whereas top traces indicate volt-
age recordings. The depolarizing current injections elicited fast action poten-
tials. (B) Voltage-dependent membrane currents. Depolarizing voltage steps
(bottom traces) elicited outward K currents and fast inward Na currents.
(C–E) TH cells (C) coexpress synaptophysin (D), which is a protein necessary for
synapse formation. Immunostaining was performed by using antibodies
against TH and synaptophysin. (F) Analyses of dopamine release. DA analysis
was performed as described in ref. 27. Results show the HPLC analyses of DA
levels in control media (control), 24 h-conditioned media (CM), and 50 mM
KCl-challenged media (KM; 30 min) after differentiation.
Fig. 3. The majority of TH neurons coexpress other markers specific for
midbrain DA neurons. The majority of TH neurons (A, D, and M) coexpress
midbrain DA markers such as AADC (B) and En1 (E) but not GABA (N).
Approximately 4% of TH (G and J) cells expressed noradrenergic or adren-
ergic markers such as DBH (4.18 0.50%; H) and PNMT (4.44 0.57%; K). ES
cell-derived neurons were stained with anti-TH (A, D, G, J, and M), anti-AADC
(DA, serotonergic; B), anti-En1 (DA; E), anti-GABA (GABAergic; N), anti-DBH
(noradrenergic and adrenergic;H), and anti-PNMT (adrenergic;K) antibodies.
(P) Semiquantitative RT-PCR analysis for neural and DA markers during in vitro
differentiation of hESCs. The expression levels of each gene were normalized
to GAPDH gene expression level. ES, undifferentiated ES cells; EB, embryoid
bodies; SNM, spherical neural mass; DA, DA neurons.
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of TH fibers and cell bodies in the striatum and the substantia
nigra, respectively (Fig. 6A). Three weeks after the 6-OHDA lesion
was generated, 5  105 differentiated neurons that had been
collected on day 7 of the 14-day differentiation procedure (Fig. 1,
stage 2) were introduced into the striatum of the lesioned side. The
effects of the grafted cells on behavioral recovery were evaluated
at the 4th, 8th, and 12th weeks after transplantation by three
behavioral tests: the apomorphine-induced rotation test (Fig. 5A),
the amphetamine-induced rotation test (Fig. 5B), and the forepaw
step-adjusting test (Fig. 5C).
We first evaluated behavioral recovery by drug-induced rotation
tests. Apomorphine and amphetamine administration into the PD
model induced a movement bias that was contralateral and ipsilat-
eral, respectively, to the lesioned side (Fig. 5A andB). In both cases,
sham control PD animals maintained a consistently high number of
rotations until the last time point measured (12 weeks posttrans-
plantation). On the contrary, the PD animals grafted with the
hESC-derived cells showed a significant reduction in rotational
scores. Apomorphine-induced rotation went down to 49.43 
1.74% (n 6) of the original level (the level before transplantation,
marked ‘‘Pre’’ in the x axis) at 12 weeks posttransplantation (Fig.
5A). Twelve weeks after the engraftment, amphetamine-induced
rotation was reduced down to 58.37  5.9% (n  6) of the levels
observed before transplantation (Fig. 5B). In normal rats, the
scores were very low (ipsilateral rotation number: 18.5/h; con-
tralateral rotation number: 11/h). Intriguingly, the pattern of the
rotation reduction was different between the two drug-induced
tests. The apomorphine-induced rotation number was rapidly re-
duced, reaching a minimal level at 4 weeks after transplantation,
and the reduced level was maintained until the 12-week time point
(Fig. 5A). In contrast, the amphetamine-induced rotation was
gradually reduced over time during the 12 weeks posttransplanta-
tion period (Fig. 5B).
The forepaw-adjusting step test reflects amore direct measure of
motor deficit because it is a nonpharmacological test. As shown in
Fig. 5C, a sham control PD group showed almost no stepping of the
disabled forepaw (contralateral to the lesioned side) throughout the
12-week period. However, the PD animals grafted with hESC-
derived cells showed a significant improvement in stepping number
over time during the 12-week period (four independent experi-
ments, n  14).
Histological Analyses of the Grafts. Twelve weeks after engraftment,
the rats were killed and then analyzed for the survival of trans-
planted hESC-derived cells with human-specific antibodies (Fig. 6).
A total number of 395,671  150,378 cells per rat (n  6, 180,672
cells per mm3, average graft size: 2.18  0.76 mm3) had survived
around the injection area and were stained with antibodies against
either human nuclei or mitochondria-specific antigen (Fig. 6).Most
of the hESC-derived cells expressed the neuronal marker III-
tubulin (Fig. 6B). We next examined the presence of hESC-derived
TH cells. In the grafts, we were able to detect TH cells that were
costained with antibody against human nuclei (Fig. 6C). The
number of TH cells were 10,732 4,132 cells per rat (2.7% of the
Fig. 5. Behavioral recovery by hESC-derived neurons in a parkinsonian rat
model. The behavior of PD animals grafted with neurons differentiated from
SNUhES1 and sham controls was tested before transplantation (Pre) and at 4,
8, and 12 weeks after the grafting. (A) Apomorphine-induced rotation re-
sponse per hour (three independent experiments until 12 weeks, n  6). (B)
Amphetamine-induced rotation response per hour (three independent ex-
periments until 12 weeks, n  6). Only rats that showed a significant turning
behavior (310 turns per hour) after drug administration were used in our
study. The rotational scores (rotation %) in A and B are expressed as a
percentage of rotations compared with the values obtained from the Pre time
point. *, significantly different from sham controls at P 0.01; **, P 0.001.
(C) The adjusting step test is expressed as the number of steps per 0.9 m on a
treadmill (at a rate of 0.075 m/s) with the disabled forepaw (four independent
experiments until 12 weeks, n  14).
Fig. 6. Characterization and survival of the transplanted cells in a parkinsonian rat model. (A) Tiled coronal sections of the rat brain showing the
6-OHDA-treated side (Left) and the cells in the injection area (human nuclei, green). The normal striatum was stained with anti-TH antibody (red). (B) The human
cells (human mitochondria, green) are predominantly III-tubulin (red), indicating that most of the human cells are neurons. (C) Twelve weeks after
transplantation, survival of TH cells was analyzed by immunohistochemistry using anti-human nuclei antibody (green) and anti-TH antibody (red). The TH cells
colocalized with human marker. (D) Ki67 cells (green) were found in the grafted region, indicating the existence of proliferating cells. (E) Oct4 cells were not
detected. (F) Association of grafted cells and astrocytes was confirmed by immunostaining using anti-human nuclei (green) and anti-GFAP (red) antibodies. (G)
Immunostaining of DAT (red) to confirm the maturity of the grafted DA neurons; human nuclei (green).














surviving hESC-derived cells, 4,901 cells per mm3). Although some
proliferating (Ki67) cells (3%) were found in the grafted area
(Fig. 6D), the cells expressing markers for undifferentiated hESCs
such asOct 4 (Fig. 6E) were not detected in the grafts.We also have
not detected teratoma formation from any animals grafted with
hESC-derived cells. Interestingly, endogenous astrocytes were lo-
cated very close to the hESC-derived cells (Fig. 6F). We observed
only a small portion of the TH neurons are expressing dopamine
transporter (DAT), suggesting thatmanyTH neurons are not fully
matured yet at 12 weeks posttransplantation (Fig. 6G).
Discussion
Efficient and large-scale generation of DA neurons from hESCs is
a very important challenge for designing a cell-replacement therapy
procedure for PD. In addition, one of the current controversial
issues is a clear demonstration of the functionality of hESC-derived
DA neurons in an animal model of PD. Although several protocols
for the differentiation of hESCs into DA neurons have been
reported (12–22, 26), protocols withmore advantages, such as those
that yield a high purity of DA neuron pool, show clear in vivo
functionality, lack the requirement for feeder cells, supply ample
quantity of DA neurons, and allow for a relatively fast differenti-
ation, are still to be developed to bring hESC-mediated cell therapy
closer to reality.
Previous protocols generate DA neurons from neural rosettes
grown attached on Matrigel. In contrast, we generate DA neurons
from SNMs that have been expanded as spheres.
Several unique procedural advantages are associated with these
SNMs. First, the hESC-derived SNMs can be coaxed into DA
neurons at the highest efficiency reported to date.Our results shows
that 77% of our cultures are neurons and 86% of the neurons are
DA neurons, indicating that 66% of the total cells are DA
neurons. These values are much higher than those in the previous
reports (i.e.,40%of total cells were reported to be TH neurons)
(12–18). Second, the SNMs can be expandable for a long time (at
least 4 months), while maintaining the same phenotype and capa-
bility to differentiate into DA neurons (Fig. 2 J–L). According to
our estimation,1.72 107 TH cells could be produced from the
four time-passaged SNMs originated from a single undifferentiated
hESC colony. The expandability of SNMswould allow us to provide
a sufficient amount of DA neurons for future clinical applications.
Third, the expanded SNMs can be stored frozen and thawed at any
time. Fourth, the generation of DA neurons from SNMs takes a
relatively short time (2 weeks). Finally, feeder cells are not used
in the SNM expansion and differentiation, which would save a lot
of time and effort required for handling feeder cells and reduce the
risk of contamination from irrelevant cells during transplantation.
Mechanical handling of the SNMs for passagingmight need some
effort. However, in our experience 100 SNMs per hour could be
passaged by mechanical manipulation and 1.2  105 TH cells
could be obtained from a single SNM after differentiation. This
mechanical work cannot be replaced by enzymatic digestion with
collagenase, trypsin, and accutase because the survival rate of the
cells becomes very low and the purification process of the SNMs
(removal of nonneural cells) cannot be achieved.
According to the immunocytochemistry and RT-PCR analyses,
the majority of the TH neurons obtained from our protocol have
the DA neuronal phenotype (Fig. 3). Only 4–5% of the TH cells
were noradrenergic or adrenergic neurons (Fig. 3G–L). GFAP and
O4-expressing cells were hardly detectable, indicating that no glial
cells were generated by the protocol (data not shown).
To determine whether the hESC-derived DA neurons could
reverse the behavioral deficits seen in a parkinsonian rat model, we
attempted to transplant the hESC-derived cells into the striatum of
the lesioned side of the PDmodel. According to our experience, the
stage of the cells during differentiation process, the condition of the
cells, and several other parameters are critical for a successful
transplantation study (11, 27). For example, if much less differen-
tiated cells are used, teratoma formation may occur; however, if
fully differentiated cells are transplanted, the survival rate is too
low. In this study, we transplanted the cells on day 7 of the 14-day
differentiation procedure. At this stage, the THgenewas beginning
to be expressed (50% of the neurons are TH; data not shown),
suggesting that these cells are being committed to DA neuronal
lineage and/or are at the initial stage of DA neuronal specification.
After injecting 500,000 cells into the striatum on the lesioned side,
we analyzed the number of surviving cells at 12 weeks posttrans-
plantation. Histochemical analyses showed that 395,671  150,378
cells were surviving, andmost of the grafted cells were neurons.We
also found that 10,732  4,132 cells (2.7% of the surviving human
cells) were TH. In contrast to the in vitro result, not many TH
cells were detected in the grafts. It is thought that two reasons are
responsible for this. First, DA neurons may be more susceptible
than other neurons to various environmental insults and stresses.
Therefore, it is possible that DA neurons were preferentially lost
during/after transplantation. Second, SNM-derived cells were
transplanted on day 7 of the 14-day differentiation procedure. At
this timepoint, some cells stillmay not committed to theDAneuron
lineage, forming other types of neurons after transplantation.
Histological analysis revealed that a small number of 5-HT
serotonergic neurons (1%) were detected and no GABAergic
neurons (GABA) were detected. Oligodendrocytes also were not
detected in the grafts [supporting information (SI) Fig. 7].
Oct4-expressing cells were not detected, although a few Ki67
cells (3%) were present (Fig. 6D and E). These data suggest that
grafted cells did not contain undifferentiated ES cells and, in line
with this observation, no teratomas were found in any of the
engrafted animals used in our study.
A successful and clear behavioral recovery has not been reported
in an animal model of PD using DA cells or DA precursor cells
derived from hESCs. One research group reported a partial be-
havioral deficit recovery by using uncommitted hESC-derived NPs
(not DA neuronal precursors) in a PD rat model. However, only
0.18  0.05% of the engrafted cells were found to become TH
neurons, thus explaining the partial behavioral recovery that they
observed (26). Very recently, Roy et al. (14) reported that hESC-
derived DA neurons generated by coculture with immortalized
midbrain astrocytes brought about behavioral recovery in an apo-
morphine-induced rotation test and the adjusting stepping test of a
PD rat model. However, as stated in a recent correspondence (23),
several questions and concerns were raised about the functionality
of the engraftment in their behavioral tests. These concerns were
over the possibility of nonspecific graft effects in their apomor-
phine-induced turning test, misinterpretation of the adjusting step
test, and a lack of clear validation of the animal model used.
In our study, we used a standard method to generate a unilateral
rat model (injection of 6-OHDA into the medial forebrain bundle)
and confirmed the level of the ipsilateral lesion by drugs (both
apomorphine and amphetamine)-induced rotation and histological
analyses (Figs. 5 and 6). Only animals that showed a significant
turning behavior (310 turns per hour) after drug administration
were selected for our behavioral study. Compared with sham
control, our cell engraftment-induced behavioral recovery was
prominent in all three tested behavioral assessments: apomorphine-
induced rotation, amphetamine-induced rotation, and forepaw-
stepping tests (Fig. 5). Interestingly, the apomorphine-induced
rotation was reduced to a minimum level as early as 4 weeks
posttransplantation (Fig. 5A). Because we cannot rule out the
possibility that this result may reflect a nonspecific effect of the
graft, as Christophersen and Brundin pointed out in their corre-
spondence (23), we tried the amphetamine-induced rotation and
forepaw-adjusting step tests. These tests are known to be better
indicators of the effect of the DA that is produced from the
surviving grafts than the apomorphine-induced rotation test (28,
29). Amphetamine-induced rotation was reduced over time during
the 12-week period posttransplantation (Fig. 5B). The forepaw-
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adjusting test (Fig. 5C) also clearly demonstrates that the disabled
paw contralateral to the lesioned side of the brain was recovered by
the grafts at the lesioned striatum, as judged by the increase in the
number of steps taken. The results from the amphetamine-induced
rotation and the forepaw-adjusting step tests evidently demonstrate
that our hESC-derived DA neurons bring about behavioral recov-
ery in a rat model of PD. Although we observed clear behavioral
recoveries in three tests we tried, we have not detected any
contralateral rotation after amphetamine treatment. One possible
reasonmight be thatmanyTH neurons are still in immature status
and are on the way to full maturation at the last time point we
performed the behavioral measurement (12 weeks after transplan-
tation). This interpretation was supported by the fact that only a
portion of the TH neurons were DAT (Fig. 6G). Furthermore,
in line with this interpretation, we have observed that the number
of amphetamine-induced turn was further decreased at 14 weeks
after transplantation (data not shown).
In conclusion, we developed an efficient protocol that can
generate functional DA neurons from hESCs at the highest yield
ever reported and, importantly, the differentiation procedure was
carried out without any genetic modification or coculture with
feeder cells, increasing safety after transplantation. In a parkinso-
nian animal model, these neurons were able to reverse the motor
deficits in all three tests commonly used to measure the efficacy of
PD therapeutic regimens. Our work also provides a method of
producing a large number of DA neurons through SNM expansion,
which might be a critical issue for future clinical applications. We
strongly believe that our study sets a firm stage for the development
of efficient therapeutic regimens for future cell-replacement ther-
apy in the treatment of PD.
Experimental Procedures
Differentiation of hESCs into DA Neurons. The undifferentiated hESC lines
SNUhES1, SNUhES3, and SNUhES16 were maintained as described in ref. 30. For
differentiation, hESC colonies were detached and were cultured in a bacterial
dish for 7 days to form EBs. EBs then were cultured in NP selection media for 5
days, and the resulting NPs were expanded for another 4 days in an expansion
medium (see SI Text). To form SNMs, neural rosettes and neural tube-like struc-
tures that were observed during neural expansion culture were mechanically
isolated and cultured onto bacterial culture dishes containing the NP expansion
medium. For passaging, the SNMs were mechanically fragmented into four to six
pieces and expanded for 7–10 days. Homogeneous SNMs generated by a
mechanical purification process during the first four passages can be expanded
foranextensivetime(4months).ThesepureSNMswereusedfordifferentiation
into DA neurons (see SI Text).
Immunostaining and Flow Cytometry Analysis. Immunostaining was performed
as described in ref. 11 (see SI Text). For flow cytometry analysis, cells were
dissociated by incubation for 5 min in 0.05% trypsin/0.1% EDTA (Invitrogen) at
37°C and then incubated in perforation solution (0.05% Triton X-100) for 5 min.
After the antibody treatment, cells were analyzed by using FACScan and
CellQuest Pro software (BD Bioscience).
RT-PCR. RT-PCR was performed as described in ref. 11. Primer sequences and the
length of the amplified products are described in SI Text.
Production of a Parkinsonian Rat Model, Cell Transplantation, and Behavioral
Testing. Male Sprague–Dawley rats weighing 200–230 g were used to generate
parkinsonian rat models. Experimental groups were divided into three groups: (i)
a normal group without lesions, (ii) a sham control group with 6-OHDA lesions,
and (iii) a group with 6-OHDA lesions that were transplanted with neurons
derived from hESCs. The detailed surgical procedures are described in the SI Text.
Two weeks after the development of 6-OHDA-induced lesions, the animals
were tested for amphetamine-induced (3 mg/kg i.p.) and apomorphine-induced
(0.1 mg/kg i.p. in saline containing AA at 2 mg/ml; Sigma) turning behavior and
forepaw-adjusting stepping, as described in ref. 27. Each forepaw-adjusting step
test consisted of five trials for the disabled forepaw.
One week after behavioral testing, hESC-derived neurons were transplanted
into the ipsilateral striatum (see SI Text). Behavioral testing was conducted after
the 4th, 8th, and 12th week posttransplantation.
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